- Company Directors - P
- Parks Fred B
Insider Trading History of Parks Fred B
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Parks Fred B since 2006.
The trader's CIK number is 1237152.
At the time of the last reporting, Parks Fred B was the Director of Nuvectra Corp. (stock ticker symbol NVTR).
Also see all insider trading activities at Nuvectra Corp.
Note that in the past
PARKS FRED B also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Viasys Healthcare Inc (VAS) by Parks Fred B
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | VAS | 0 | $0 | 0 | $0 | 10,631 | $248,499 |
Yearly summary of insider trading at Nuvectra Corp (NVTR) by Parks Fred B
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | NVTR | 0 | $0 | 0 | $0 | 1,674 | $21,878 |
2018 | NVTR | 0 | $0 | 0 | $0 | 3,350 | $53,498 |
2017 | NVTR | 0 | $0 | 0 | $0 | 3,350 | $32,283 |
2016 | NVTR | 0 | $0 | 0 | $0 | 1,676 | $11,537 |
Yearly summary of insider trading at Urologix Inc (ULGX) by Parks Fred B
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | ULGX | 6,865 | $11,086 | 0 | $0 | 0 | $0 |
2006 | ULGX | 16,085 | $54,688 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Analogic Corp (ALOG) by Parks Fred B
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ALOG | 0 | $0 | 0 | $0 | 35,514 | $0 |
2017 | ALOG | 0 | $0 | 0 | $0 | 18,722 | $0 |
2014 | ALOG | 0 | $0 | 10,000 | $763,279 | 10,000 | $567,272 |
Insider trading activities at 4 companies by Parks Fred B:
1. Viasys Healthcare Inc (VAS)
2. Nuvectra Corp (NVTR)
3. Urologix Inc (ULGX)
4. Analogic Corp (ALOG)
Table 1. Insider trading of Viasys Healthcare Inc (VAS) by Parks Fred B
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-06-28 | VAS | Option Ex | 10,631 | 23.38 | 248,499 |
Table 2. Insider trading of Nuvectra Corp (NVTR) by Parks Fred B
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-04-09 | NVTR | Option Ex | 837 | 10.51 | 8,796 |
2019-01-09 | NVTR | Option Ex | 837 | 15.63 | 13,082 |
2018-10-09 | NVTR | Option Ex | 838 | 23.19 | 19,433 |
2018-07-09 | NVTR | Option Ex | 838 | 17.36 | 14,547 |
2018-04-10 | NVTR | Option Ex | 837 | 13.53 | 11,324 |
2018-01-10 | NVTR | Option Ex | 837 | 9.79 | 8,194 |
2017-10-10 | NVTR | Option Ex | 838 | 13.87 | 11,623 |
2017-07-10 | NVTR | Option Ex | 838 | 12.73 | 10,667 |
2017-04-07 | NVTR | Option Ex | 837 | 6.36 | 5,323 |
2017-01-07 | NVTR | Option Ex | 837 | 5.58 | 4,670 |
2016-10-07 | NVTR | Option Ex | 839 | 6.53 | 5,478 |
2016-07-07 | NVTR | Option Ex | 837 | 7.24 | 6,059 |
Table 3. Insider trading of Urologix Inc (ULGX) by Parks Fred B
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-11-02 | ULGX | Buy | 6,865 | 1.61 | 11,086 |
2006-05-15 | ULGX | Buy | 13,351 | 3.40 | 45,393 |
2006-05-16 | ULGX | Buy | 2,734 | 3.40 | 9,295 |
Table 4. Insider trading of Analogic Corp (ALOG) by Parks Fred B
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-06-22 | ALOG | Option Ex | 35,514 | .00 | 0 |
2017-09-14 | ALOG | Option Ex | 17,104 | .00 | 0 |
2017-05-01 | ALOG | Option Ex | 1,618 | .00 | 0 |
2014-12-12 | ALOG | Option Ex | 1,666 | 48.01 | 79,984 |
2014-12-12 | ALOG | Sale | 1,666 | 85.20 | 141,938 |
2014-06-11 | ALOG | Option Ex | 8,334 | 58.47 | 487,288 |
2014-06-11 | ALOG | Sale | 8,334 | 74.56 | 621,341 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Parks Fred B
(Director of Nuvectra Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.